Skip To Content

Resources Library

Application Notes

Improving Method Transfer Outcomes

ACD/Labs and the Separation SME team at Pfizer collaborated to create a feature within Method Selection Suite to vary method parameters. With this tool methods are automatically generated for all possible combinations of parameter variations—enabling seamless method transfer without impacting method performance.
Application Notes

Accurate and Reproducible Quantitation of xC/UV/MS Data from Any Instrument

Process and quantify all xC/UV/MS data in a single software interface from any instrument. Learn how to consistently achieve reliable and accurate results using the quantitation workflow in MS Workbook Suite.
Application Notes

Accelerated Stability Assessment with Luminata

This application note explores how Luminata can be used to accelerate and simplify your stability assessment data management.
Application Notes

Eliminating the Logistical Challenges of NMR Data Processing with Browser-Based Software

This application note describes the implementation of Spectrus Processor JS in a natural products researcher’s workflow. The program was used…
Application Notes

Multi-Technique, Vendor Neutral Analytical Data Handling for Chemists

Read how to process, interpret & report analytical data from all major vendor formats in one application and help answer the question "Did I make what I think I made?"
Application Notes

Implementing Modern IUPAC Nomenclature

See how ACD/Name is keeping ahead of the growing complexity of chemical nomenclature.
Application Notes

Workflow for Chemical Characterization and Database Curation for LC/MS and GC/MS Data

Using the structure verification and knowledge management capabilities in MS Structure ID Suite, Medtronic has created a data-handling workflow for chemical characterization and database curation.
Application Notes

Applying QbD in Process and Impurity Control Strategy Development

Quality-by-Design (QbD) is a modern approach to impurity control supported by pharmaceutical industry regulators. Pharmaceutical development groups need support from…